Pyrrolidine-Containing Polypyridines: New Ligands for Improved Visible Light Absorption by Ruthenium Complexes
摘要:
A range of new electron-releasing pyrrolidine-containing bipyridines and terpyridines has been prepared via selective metalation-cross-coupling sequences. The obtained ligands have been involved in microwave-assisted ruthenium complexation leading to homoleptic complexes in high yield. The electron-donor effect of the pyrrolidine nucleus led to a notable improvement of visible light absorption and strong changes in the electrochemical behavior, opening new opportunities for the design of photovoltaic devices.
Pyrrolidine-Containing Polypyridines: New Ligands for Improved Visible Light Absorption by Ruthenium Complexes
摘要:
A range of new electron-releasing pyrrolidine-containing bipyridines and terpyridines has been prepared via selective metalation-cross-coupling sequences. The obtained ligands have been involved in microwave-assisted ruthenium complexation leading to homoleptic complexes in high yield. The electron-donor effect of the pyrrolidine nucleus led to a notable improvement of visible light absorption and strong changes in the electrochemical behavior, opening new opportunities for the design of photovoltaic devices.
Novel pyridine compounds, process for their preparation and compositions containing them
申请人:Pal Manojit
公开号:US20060084644A1
公开(公告)日:2006-04-20
The present invention provides new heterocyclic compounds, particularly substituted pyridines, methods and compositions for making and using these heterocyclic compounds, and methods for treating a variety of diseases and disease states, including atherosclerosis, arthritis, restenosis, diabetic nephropathy, or dyslipidemia, or disease states mediated by the low expression of Perlecan.
Pyridine compounds, process for their preparation and compositions containing them
申请人:Reddy US Therapeutics, Inc.
公开号:US07622486B2
公开(公告)日:2009-11-24
The present invention provides new heterocyclic compounds, particularly substituted pyridines, methods and compositions for making and using these heterocyclic compounds, and methods for treating a variety of diseases and disease states, including atherosclerosis, arthritis, restenosis, diabetic nephropathy, or dyslipidemia, or disease states mediated by the low expression of Perlecan.
Numerous appropriately substituted pyridyl or phenyl groups serve as a particularly advantageous activation motif for the electrochemical oxidation of amines. Such groups enable a general, mild method for the electrochemical α‐functionalization of tertiary amines across numerous activating groups and amine scaffolds. Notably, the method accommodates an unprecedented range of nucleophile classes, allowing
许多适当取代的吡啶基或苯基用作胺的电化学氧化的特别有利的活化基序。这些基团为跨众多活化基团和胺支架的叔胺电化学α-官能化提供了一种通用、温和的方法。值得注意的是,该方法适应了前所未有的亲核试剂类别,允许将不同的官能团引入易于制备的胺底物中。然后通过不对称双功能化、N-吡啶胺与其他活性胺的位点选择性功能化、ivosidenib 的正式合成以及 FDA 批准的药物或天然产物底物的多样化的应用来证明该方法的实用性。
Parallel synthesis of 4-amino-2,6-dialkylamino-pyridines
In this letter a fast and useful parallel synthesis approach to 4-amino-2,6-dialkylamino-pyridines is described starting from commercially available 2,6-difluoro-3,5-dichloro-pyridine. Both symmetrical and unsymmetrical derivatives have been synthesized respectively in two or three steps in good yields. The method described is mild, adaptable to combinatorial purposes and applicable to a variety of amines. (C) 2002 Elsevier Science Ltd. All rights reserved.